Participants 29 57 3
patients with limb ischaemia
Participants 360 395 4
We investigated efficacy and safety
Participants 459 527 4
patients with ischaemic limbs because of peripheral arterial disease
Participants 574 632 6
25 patients (group A) with unilateral ischaemia of the leg
Participants 791 842 6
22 patients (group B) with bilateral leg ischaemia,
Participants 1132 1191 5
Two patients were excluded from group B after randomisation
Participants 1207 1223 3
group B patients
Participants 1693 1709 5
group A patients
Participants 1712 1723 3
wo patients
Participants 1727 1734 3
group A
